EQS-News: MPH Health Care AG publishes Annual Report 2025 The Executive Board and Supervisory Board will propose an increased dividend of €5.00 per share to the Annual General Meeting on 9 July 2026
|
EQS-News: MPH Health Care AG
/ Key word(s): Annual Report/Annual Results
MPH Health Care AG publishes Annual Report 2025
The Executive Board and Supervisory Board will propose an increased dividend of €5.00 per share to the Annual General Meeting on 9 July 2026
The full Annual Report is now available to download from the company’s website at www.mph-ag.de under the Investor Relations section. About MPH Health Care AG: MPH Health Care AG is an investment company with a strategic focus on the acquisition, development and sale of companies and shareholdings, particularly in growth segments of the healthcare market. This includes both insurance-funded and privately funded segments. However, MPH also capitalises on opportunities arising in high-growth, high-profit sectors outside the healthcare market. Contact: Patrick Brenske, Management Board Corporate Communications E-Mail: ir@mph-ag.de
27.05.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | MPH Health Care AG |
| Grünauer Straße 5 | |
| 12557 Berlin | |
| Germany | |
| Phone: | 030 / 863 21 45 60 |
| Fax: | 030 / 863 21 45 69 |
| E-mail: | info@mph-ag.de |
| Internet: | www.mph-ag.de |
| ISIN: | DE000A289V03 |
| WKN: | A289V0 |
| Listed: | Regulated Unofficial Market in Dusseldorf, Frankfurt (Basic Board), Munich, Stuttgart, Tradegate BSX |
| EQS News ID: | 2333814 |
| End of News | EQS News Service |
|
|
2333814 27.05.2026 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | ||
| Sales1 | 3,43 | 13,55 | 30,67 | 34,46 | 65,36 | 50,18 | 0,00 | |
| EBITDA1,2 | -70,99 | -9,05 | 29,59 | 29,54 | 32,99 | -28,45 | 0,00 | |
| EBITDA-Margin3 | -2.069,68 | -66,79 | 96,48 | 85,72 | 50,47 | -56,69 | 0,00 | |
| EBIT1,4 | -71,02 | -9,07 | 29,56 | 30,21 | 32,96 | -28,50 | 0,00 | |
| EBIT-Margin5 | -2.070,55 | -66,94 | 96,38 | 87,67 | 50,43 | -56,80 | 0,00 | |
| Net Profit (Loss)1 | -70,38 | -8,96 | 29,11 | 29,54 | 32,04 | -29,33 | 0,00 | |
| Net-Margin6 | -2.051,90 | -66,13 | 94,91 | 85,72 | 49,02 | -58,44 | 0,00 | |
| Cashflow1,7 | -2,89 | -1,09 | 0,01 | -2,02 | 1,83 | 0,13 | 0,00 | |
| Earnings per share8 | -16,44 | -2,09 | 6,80 | 6,90 | 7,48 | -6,85 | 1,20 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 1,20 | 1,20 | 5,00 | 0,50 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: wetreu NTRG
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| MPH Health Care | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A289V0 | DE000A289V03 | AG | 113,03 Mio € | 01.09.2009 | Kaufen | 9F4MCHV9+6R |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 16,50 | 7,75 | 2,13 | 6,06 | 0,51 | 869,45 | 2,25 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 1,20 | 1,20 | 5,00 | 18,94% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 09.07.2026 | 10.06.2026 | 16.09.2026 | 25.11.2026 | 27.05.2026 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +26,85% | +28,34% | +20,00% | +2,72% | +0,00% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
